|
Sánchez-Más J, Lax A, Asensio-López MC, Fernández-Del Palacio MJ, Caballero L, Navarro-Peñalver M, Pérez-Martínez MT, Gimeno-Blanes JR, Pascual-Figal DA. The TBX1 Transcription Factor in Cardiac Remodeling After Myocardial Infarction. Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1042-1050. doi: 10.1016/j.rec.2016.04.033. Epub 2016 Jul 12. English, Spanish. PubMed PMID: 27422448.
AÑO: 2016; IF: 4.485
|
27422448
|
Sanchez-Mas J, Saura-Guillen E, Asensio-Lopez MC, Soriano-Filiu A, Carmen Sanchez-Perez M, Hernandez-Martinez AM, Lax A, Pascual-Figal D. Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction. Diabetes Metab. 2019 Apr;45(2):201-204. doi: 10.1016/j.diabet.2017.09.008. Epub 2017 Oct 31. No abstract available. PubMed PMID: 29097004.
AÑO: 2019; IF: 4.731
|
|
Asensio-López MC, Soler F, Pascual-Figal D, Fernández-Belda F, Lax A. Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes. PLoS One. 2017 Feb 28;12(2):e0172803. doi: 10.1371/journal.pone.0172803. eCollection 2017. PubMed PMID: 28245258; PubMed Central PMCID: PMC5330507.
AÑO: 2017; IF: 2.766
|
|
Pérez-Martínez MT, Lacunza-Ruiz J, García de Lara J, Noguera-Velasco JA, Lax A, Hernández-Vicente Á, Asensio-López MC, Januzzi JL Jr, Ibañez B, Pascual-Figal DA. Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2018 Sep 18;72(12):1429-1430. doi: 10.1016/j.jacc.2018.06.062. PubMed PMID: 30213338.
AÑO: 2018; IF: 18.639
|
|
Asensio-Lopez MDC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Pascual-Figal DA. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction. Transl Res. 2018 Sep;199:4-23. doi: 10.1016/j.trsl.2018.04.004. Epub 2018 Apr 23. PubMed PMID: 29753686.
AÑO: 2018; IF: 4.915
|